Dual-Mechanism of Action

OIS@SECO2019 Presentation Dual-Mechanism of Action

CEO Dr. Brian Lawrence, PhD, presented an overview of SilkTech’s biologic drug candidate SDP-4 at OIS@SECO2019. The audience of over 200 Optometrists and other eye care professionals learned of novel drug SDP-4’s dual-mechanism of action to treat the signs and symptoms of Dry Eye Disease. To view Dr. Lawrence’s presentation, please click HERE
#Optometrists #DryEye #Innovation #EyeCare

Leave a Comment